This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Altria Stock be in Your Portfolio Ahead of Q3 Earnings?
by Vrishali Bagree
Altria faces challenges from macroeconomic pressures and a surge in illegal e-vapor products, though smoke-free offerings provide some support.
Philip Morris Hits Record High on Q3 Earnings Beat: ETFs in Focus
by Yashwardhan Jain
Look at ETFs with exposure to Philip Morris, as the tobacco giant beats earnings estimates and surges to a record high.
Philip Morris (PM) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Philip Morris (PM) possesses solid growth attributes, which could help it handily outperform the market.
Company News for Oct 23, 2024
by Zacks Equity Research
Companies in The News Are: AGNC, PM, CADE, VZ
Record Earnings: Should Investors Buy Philip Morris Stock Now?
by Ethan Feller
Philip Morris International has staged a massive rally on the back of its rapidly growing smokeless segment
PM Q3 Earnings Top Estimates on Combustible Pricing, 2024 View Up
by Zacks Equity Research
Philip Morris' third-quarter 2024 results reflect robust momentum across all regions and product categories. Management raises guidance for 2024.
Philip Morris (PM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Philip Morris (PM) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Philip Morris (PM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 4.37% and 3.55%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Philip Morris' Q3 Earnings Coming Up: Here's What You Should Know
by Zacks Equity Research
Philip Morris' Q3 results are likely to reflect gains from pricing and strength in smoke-free products, especially IQOS and ZYN.
Is Freshpet (FRPT) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Freshpet (FRPT) and Philip Morris (PM) have performed compared to their sector so far this year.
Unveiling Philip Morris (PM) Q3 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Philip Morris (PM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
The Zacks Analyst Blog Meta, Cisco, Philip Morris, Earth Science Tech and Frequency Electronics
by Zacks Equity Research
Meta, Cisco, Philip Morris, Earth Science Tech and Frequency Electronics are included in this Analyst Blog.
Top Analyst Reports for Meta Platforms, Cisco & Philip Morris
by Santanu Roy
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Cisco Systems, Inc. (CSCO) and Philip Morris International Inc. (PM), as well as two micro-cap stocks Earth Science Tech, Inc. (ETST) and Frequency Electronics, Inc. (FEIM).
Will Philip Morris (PM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
STZ Q2 Earnings: Will Soft Wine & Spirits Trends to Mar Results?
by Zacks Equity Research
Soft demand trends and category headwinds in the wine & spirits business are expected to affect Constellation Brands in Q2, offset by a resilient beer segment.
Is Philip Morris International (PM) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Philip Morris (PM) and Pilgrim's Pride (PPC) have performed compared to their sector so far this year.
Altria Stock Trading Above 200 & 50-Day SMA: Is it a Good Time to Buy?
by Vrishali Bagree
Altria's strong brand equity and growing presence in the smoke-free product space provide a solid foundation for resilience in a competitive landscape.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDIV
What Does Philip Morris's Sale of Vectura Group Mean for its Future? (Revised)
by Zacks Equity Research
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
Philip Morris Stock Trading Above 200 & 50-Day SMA: Should You Buy?
by Zacks Equity Research
Philip Morris is poised for success, bolstered by its robust momentum, commitment to innovative smoke-free solutions and ability to drive profitability.
What Does Philip Morris's Sale of Vectura Group Mean for its Future?
by Zacks Equity Research
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
Why Philip Morris (PM) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.